glutathione nasal spray me/cfs - 12ML Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS):
Description
Lee M, Im W, Kim M

McCracken, C

doi: 10.1016/j.jff.2021.104504

Treatment with ES2 or Dabrafenib did not alter survival times

Additionally, BPC-157 exhibits neuroprotective effects and may influence dopaminergic and serotonergic systems
